About Apellis Pharma (APLS)
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more
- USD17.69
- USD19.02
- USD17.41
- USD43.99
- -2.90%
- 776M
- 108.00
- 3.13M
- 2.2B
- 16.10
- -57.20%
Stock News
6 hours ago
The Evolution Of Marketplace Convenience
SeekingAlpha
6 hours ago
Warby Parker's Partnership With Alphabet Doesn't Change Things
SeekingAlpha
6 hours ago
Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity
SeekingAlpha
6 hours ago
Rates Spark: Long End Pressured With Dutch Pension Reform On Course
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
